About
Basic Data Updated:
4 days agoSyngene International Limited, an India-based contract research organisation, is known for its comprehensive range of services in the fields of discovery, development, and manufacturing. These services cater to a diverse range of industries, including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic, and nutrition companies. The company is also involved in conducting exploratory and discovery studies, as well as various toxicity studies such as in vitro and in vivo gentox, developmental and reproductive, acute, sub-chronic, and chronic toxicity studies. Additionally, the company provides development services for biologics. In addition to its extensive range of services, Syngene International Limited also offers clinical trials, bio-availability/bio-... Read More
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
Financials of Syngene International Limited
Enhance accessibility to Syngene International's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Syngene International's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Syngene International Limited
Unlock and access historical data on people associated with Syngene International, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
Priyadarshini Mahapatra
Company SecretaryAppointment Date: 24-Jul-2019
Status: Current
Jonathan Hunt
Managing DirectorAppointment Date: 01-May-2017
Status: Current
SB
Sibaji Biswas CFOAppointment Date: 18-Dec-2019
Status: Current
Board Members(7)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Mar 2021 | ₹375.00 Cr | Open |
Others Creation Date: 03 Aug 2021 | ₹370.03 Cr | Satisfied |
Others Creation Date: 15 Sep 2016 | ₹670.00 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Syngene International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syngene International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
75 years 3 months 
Recent activity within the organization
Charges
A charge registered on 03 Aug 2021 via Charge ID 100471904 with Others was fully satisfied on 10 Nov 2023.
10 Nov 2023Annual General Meeting
Syngene International Limited last Annual general meeting of members was held on 26 Jul 2023 as per latest MCA records.
26 Jul 2023Balance Sheet
Syngene International Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
31 Mar 2023Charges
A charge registered on 29 Jul 1994 via Charge ID 90196748 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 20 Sep 2022.
20 Sep 2022Charges
A charge registered on 15 Sep 2016 via Charge ID 100051271 with Others was fully satisfied on 18 May 2022.
18 May 2022
Recent News, Updates & Announcement
Syngene and I A Dynamic Duos Patent Success CollaborationGoals PatentPower.Me and Syngene made a patent together Were basically geniuses CollaborationGoals PatentPower.
Panbela Therapeutics, Inc 31 Oct 2023
- Dynamic Duo Charpentier and I Take Home Nobel Prize for Chemistry and Dominate with ERS Genomics Company.
Me and my girl Emmanuelle Charpentier just won a Nobel Prize for our sick chemistry skills We started a company called ERS Genomics and were killing it NobelPrize Chemistry BossBabes.
PR Newswire 19 Oct 2023
- Syngene Q1 Results PAT up 26 to 93 crore revenue rises 26 to 832 crore Mint.
The firm said that the EBITDA was 235 crore for Q1FY24 and the margin was 283 percent.
mint 27 Jul 2023
- Syngene to acquire multimodal facility from Stelis Biopharma.
To add 20000 litres of installed biologics drug substance manufacturing capacity Syngene announced the acquisition of Unit 3 biologics manufacturing facility in Bengaluru from Stelis Biopharma Limit.
IndiaMedToday 05 Jul 2023
Frequently asked questions
What is the Incorporation or founding date of Syngene International Limited?
